| [1] |
Cavallaro A, Piccolo G, Di Vita M, et al. Managing the incidentally detected gallbladder cancer: algorithms and controversies[J]. Int J Surg, 2014, 12 Suppl 2:S108-119.
|
| [2] |
Babu BI, Dennison AR, Garcea G. Management and diagnosis of gallbladder polyps: a systematic review[J]. Langenbecks Arch Surg, 2015, 400(4):455-462.
|
| [3] |
Andrén-Sandberg A. Diagnosis and management of gallbladder polyps[J]. N Am J Med Sci, 2012, 4(5):203-211.
|
| [4] |
Jang JY, Kim SW, Lee SE, et al. Differential diagnostic and staging accuracies of high resolution ultrasonography, endoscopic ultrasonography, and multidetector computed tomography for gallbladder polypoid lesions and gallbladder cancer[J]. Ann Surg, 2009, 250(6):943-949.
|
| [5] |
Kim JH, Lee JY, Baek JH, et al. High-resolution sonography for distinguishing neoplastic gallbladder polyps and staging gallbladder cancer[J]. AJR Am J Roentgenol, 2015, 204(2):W150-159.
|
| [6] |
Jenssen C, Alvarez-Sánchez MV, Napoléon B, et al. Diagnostic endoscopic ultrasonography: assessment of safety and prevention of complications[J]. World J Gastroenterol, 2012, 18(34):4659-4676.
|
| [7] |
Wiles R, Thoeni RF, Barbu ST, et al. Management and follow-up of gallbladder polyps: joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery-European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE)[J]. Eur Radiol, 2017, 27(9): 3856-3866.
|
| [8] |
Bhatt NR, Gillis A, Smoothey CO, et al. Evidence based management of polyps of the gall bladder: a systematic review of the risk factors of malignancy[J]. Surgeon, 2016, 14(5):278-286.
|
| [9] |
Zielinski MD, Atwell TD, Davis PW, et al. Comparison of surgically resected polypoid lesions of the gallbladder to their pre-operative ultrasound characteristics[J]. J Gastrointest Surg, 2009, 13(1):19-25.
|
| [10] |
Singh S, Agarwal AK. Gallbladder cancer: the role of laparoscopy and radical resection[J]. Ann Surg, 2009, 250(3):494-495.
|
| [11] |
Amini N, Kim Y, Wilson A, et al. Prognostic implications of lymph node status for patients with gallbladder cancer: a multi-institutional study[J]. Ann Surg Oncol, 2016, 23(9):3016-3023.
|
| [12] |
Tseng JH, Wan YL, Hung CF, et al. Diagnosis and staging of gallbladder carcinoma. evaluation with dynamic MR imaging[J]. Clin Imaging, 2002, 26(3):177-182.
|
| [13] |
Rodríguez-Fernández A, Gómez-Río M, Medina-Benítez A, et al. Application of modern imaging methods in diagnosis of gallbladder cancer[J]. J Surg Oncol, 2006, 93(8):650-664.
|
| [14] |
Pandey M, Sood BP, Shukla RC, et al. Carcinoma of the gallbladder: role of sonography in diagnosis and staging[J]. J Clin Ultrasound, 2000, 28(5):227-232.
|
| [15] |
Okada H, Uchida Y, Matsuzaki N, et al. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder[J]. World J Surg Oncol, 2016, 14(1):284.
|
| [16] |
Adachi T, Haraguchi M, Irie J, et al. Gallbladder small cell carcinoma: a case report and literature review[J]. Surg Case Rep, 2016, 2(1):71.
|
| [17] |
Coburn NG, Cleary SP, Tan JC, et al. Surgery for gallbladder cancer: a population-based analysis[J]. J Am Coll Surg, 2008, 207(3):371-382.
|
| [18] |
Lee AJ, Chiang YJ, Lee JE, et al. Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines[J]. J Surg Res, 2018(230):148-154.
|
| [19] |
Lee SE, Jang JY, Lim CS, et al. Systematic review on the surgical treatment for T1 gallbladder cancer[J]. World J Gastroenterol, 2011, 17(2):174-180.
|
| [20] |
Wakai T. Frontline in the management of gallbladder cancer[J]. Nihon Shokakibyo Gakkai Zasshi, 2013, 110(8):1392-1399.
|
| [21] |
Isambert M, Leux C, Métairie S, et al. Incidentally-discovered gallbladder cancer: when, why and which reoperation?[J]. J Visc Surg, 2011, 148(2):e77-84.
|
| [22] |
Goetze TO, Paolucci V. Immediate re-resection of T1 incidental gallbladder carcinomas: a survival analysis of the German Registry[J]. Surg Endosc, 2008, 22(11):2462-2465.
|
| [23] |
Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study[J]. Ann Surg, 2015, 261(4):733-739.
|
| [24] |
Lee W, Jeong CY, Jang JY, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? results of a retrospective multicenter study[J]. Surgery, 2017, 162(3):515-524.
|
| [25] |
Goetze TO, Paolucci V. Incidental T1b-T3 gallbladder carcinoma. extended cholecystectomy as an underestimated prognostic factor-results of the German registry[J]. Chirurg, 2014, 85(2):131-138.
|
| [26] |
Zaidi MY, Maithel SK. Updates on gallbladder cancer management[J]. Curr Oncol Rep, 2018, 20(2):21.
|
| [27] |
Lee SE, Kim KS, Kim WB, et al. Practical guidelines for the surgical treatment of gallbladder cancer[J]. J Korean Med Sci, 2014, 29(10): 1333-1340.
|
| [28] |
Shirai Y, Wakai T, Sakata J, et al. Regional lymphadenectomy for gallbladder cancer: rational extent, technical details, and patient outcomes[J]. World J Gastroenterol, 2012, 18(22):2775-2783.
|
| [29] |
Kim BH, Kwon J, Chie EK, et al. Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: a systematic review and meta-analysis[J]. Ann Surg Oncol, 2018, 25(1):255-264.
|
| [30] |
Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome[J]. Clin Epidemiol, 2014(6):99-109.
|
| [31] |
Hyder O, Dodson RM, Sachs T, et al. Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis[J]. Surgery, 2014, 155(1):85-93.
|
| [32] |
Kim WS, Choi DW, You DD, et al. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma[J]. J Gastrointest Surg, 2010, 14(4):679-687.
|
| [33] |
Wang SJ, Lemieux A, Kalpathy-Cramer J, et al. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer[J]. J Clin Oncol, 2011, 29(35):4627-4632.
|
| [34] |
Rojas-Sepúlveda D, Tittarelli A, Gleisner MA, et al. Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer[J]. Cancer Immunol Immunother, 2018, 67(12):1897-1910.
|
| [35] |
El-Khoueiry AB, Rankin C, Siegel AB, et al. S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma[J]. Br J Cancer, 2014, 110(4):882-887.
|
| [36] |
Kim ST, Jang KT, Lee SJ, et al. Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase Ⅲ study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer[J]. BMC Cancer, 2015(15): 530.
|